Tesi etd-09142022-113229 |
Link copiato negli appunti
Tipo di tesi
Tesi di laurea magistrale
Autore
PAPI, MARGHERITA
URN
etd-09142022-113229
Titolo
Development of the QMS structure and related documentation for clinical investigation of novel 3D-printed resorbable scaffolds manufactured by BellaSeno according to EU MDR, FDA and TGA Regulations.
Dipartimento
INGEGNERIA DELL'INFORMAZIONE
Corso di studi
INGEGNERIA BIOMEDICA
Relatori
relatore Prof. Vozzi, Giovanni
supervisore Dott. Chhaya, Mohit Prashant
supervisore Dott. Chhaya, Mohit Prashant
Parole chiave
- class III implantable medical devices
- clinical investigation
- quality management system
- standard operating procedure
Data inizio appello
07/10/2022
Consultabilità
Non consultabile
Data di rilascio
07/10/2092
Riassunto
Clinical Investigations (CIs) are studies in human subjects to demonstrate the safety and the clinical performance of a medical device. As manufacturer of Class III implantable medical devices, BellaSeno must conduct CIs to generate reliable clinical data to place the novel 3D-printed resorbable scaffolds on the European market. Every aspect of this complex process must be outlined in written quality procedures, enforcing a standardized process to ensure the success of a study. Standard Operating Procedures (SOPs) to conduct CIs have been developed in this thesis work, splitting the overall process into different phases before, during and after the beginning of the study. Considering that the company is interested in performing CIs in Europe, United States and Australia, the elaborated procedures are in compliance with EU MDR 2017/745, FDA and TGA Regulations. Together with the developed SOPs, original templates, forms, and checklists have been designed in this thesis work to support BellaSeno in the management of current and future CIs.
File
Nome file | Dimensione |
---|---|
La tesi non è consultabile. |